Lung Cancer Warning May Be Last Gasp for Inhaled Insulin

Pfizer said this morning that it’s adding a warning about lung cancer to the labeling for its inhaled insulin Exubera. The number of cases is low — six out of 4,740 patients treated with the drug, compared with one case out of 4,292 comparable patients who did not receive the drug. It’s not clear whether [...]